FDA Inspection 704851 — Bausch & Lomb Incorporated

Bausch & Lomb Incorporated — FEI 1032500

The FDA completed an inspection of Bausch & Lomb Incorporated on December 17, 2010 in Greenville, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 17, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Greenville, SC (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed
191421 CFR 211.166(a)Lack of written stability program
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures